Epinoma

Epinoma is a multiomics company that harnesses epigenetics to diagnose health disorders. Epigenetics is the expression of genetic code and current products in this area suffer from low accuracy, late interventions, and limited actionability. Epinoma’s blood test is an order of magnitude more sensitive with a much faster processing time. The conditions the company is targeting are colon cancer, glioblastoma, breast cancer, and lung cancer. As it refines its technological approach, Epinoma will also develop targeted therapeutics.